Sickle cell drug safety study ends early
NCT ID NCT05632354
First seen Mar 26, 2026 · Last updated May 09, 2026 · Updated 4 times
Summary
This study was designed to check the long-term safety of the drug GBT021601 in people with sickle cell disease who had already taken it in a previous study. It included 47 participants aged 6 months and older. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aminu kano Teaching Hospital
Kano, 700233, Nigeria
-
Inova Schar Cancer Institute
Fairfax, Virginia, 22031, United States
-
Lagos University Teaching Hospital
Lagos, 100254, Nigeria
-
Mississippi Center for Advanced Medicine
Madison, Mississippi, 39110, United States
-
Our Lady of the Lake Hospital, Inc.
Baton Rouge, Louisiana, 70808, United States
-
University College Hospital Ibadan
Ibadan, Oyo/ibadan North, 200212, Nigeria
-
University Medical Center Inpatient Pharmacy
New Orleans, Louisiana, 70112, United States
-
University Medical Center New Orleans
New Orleans, Louisiana, 70112, United States
-
University of Texas Health Science Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.